EMEND Side Effects

7010883-7 | Face Oedema, Hypotension, Malaise, Oedema Mouth, Pyrexia, Rash, Unresponsive To Stimuli
on Sep 16, 2010 Female patient from UNITED KINGDOM , 41 years of age, was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, hypotension, malaise, oedema mouth, pyrexia, rash (What is rash?), unresponsive to stimuli. Emend dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), THIAMINE (View Thiamine Review and Thiamine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ).

7006455-0 | Febrile Neutropenia
Patient was taking Emend (View Usage). Patient had the following side effects: febrile neutropenia on Sep 16, 2010 from FRANCE Additional patient health information: Female patient , 65 years of age, . Emend dosage: . During the same period patient was treated with BLEOMYCIN (View Bleomycin Review and Bleomycin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DEXCHLORPHENIRAMINE MALEATE (View Dexchlorpheniramine Maleate Review and Dexchlorpheniramine Maleate Label ). Patient was hospitalized.

6992701-6 | Cardiac Failure Congestive
Adverse event was reported on Sep 09, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: JAPAN , 73 years of age, After Emend was administered, patient had the following side effects: cardiac failure congestive. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ALOXI (View Aloxi Review and Aloxi Label ), TS 1 (View Ts-1 Review and Ts-1 Label ).

6992692-8 | Dysgeusia, Liver Disorder, Neuropathy Peripheral, Renal Disorder
on Sep 09, 2010 Male patient from JAPAN , 47 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, liver disorder, neuropathy peripheral, renal disorder. Emend dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ), LASIX (View Lasix Review and Lasix Label ), BRIPLATIN (View Briplatin Review and Briplatin Label ), CLEANAL (View Cleanal Review and Cleanal Label ), MOBIC (View Mobic Review and Mobic Label ).


6978965-3 | Decreased Appetite, Depressive Symptom, Dizziness, Dyspnoea, Headache, Palpitations
on Aug 31, 2010 Female patient from JAPAN , 46 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient had the following side effects: decreased appetite, depressive symptom, dizziness (What is dizziness?), dyspnoea, headache (What is headache?), palpitations. Emend dosage: . During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ), DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

6977096-6 | Inappropriate Antidiuretic Hormone Secretion
Patient was taking Emend (View Usage). After Emend was administered, patient had the following side effects: inappropriate antidiuretic hormone secretion on Sep 03, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Emend dosage: . During the same period patient was treated with PLATOSIN (View Platosin Review and Platosin Label ), VEPESID (View Vepesid Review and Vepesid Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), OMEPRAL (View Omepral Review and Omepral Label ), LASTET (View Lastet Review and Lastet Label ). Patient was hospitalized.

6971799-5 | Liver Disorder
Adverse event was reported on Aug 30, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), DECADRON (View Decadron Review and Decadron Label ), SEROTONE (View Serotone Review and Serotone Label ), VITAMEDIN (View Vitamedin Review and Vitamedin Label ). Patient was hospitalized.

6968737-8 | Convulsion, Depressed Level Of Consciousness, Epistaxis, Fall
on Aug 26, 2010 Male patient from JAPAN , 27 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient had the following side effects: convulsion, depressed level of consciousness, epistaxis, fall (What is fall?). Emend dosage: . During the same period patient was treated with MAGLAX (View Maglax Review and Maglax Label ), GASLON N (View Gaslon N Review and Gaslon N Label ), LOBU (View Lobu Review and Lobu Label ), SELBEX (View Selbex Review and Selbex Label ), PEMIROC (View Pemiroc Review and Pemiroc Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

6965741-0 | Erythema Multiforme, Toxic Epidermal Necrolysis
on Aug 31, 2010 Female patient from UNITED KINGDOM , 44 years of age, weighting 154.3 lb, was diagnosed with nausea (What is nausea?), gastrooesophageal reflux disease, dyspepsia and was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: erythema multiforme, toxic epidermal necrolysis. Emend dosage: . During the same period patient was treated with CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), POTASSIUM BICARBONATE AND SODIUM ALGINATE (View Potassium Bicarbonate And Sodium Alginate Review and Potassium Bicarbonate And Sodium Alginate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6961034-6 | Gastric Ulcer Haemorrhage
Patient was taking Emend (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer haemorrhage on Aug 25, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with prophylaxis of nausea and vomiting, colon cancer and. Emend dosage: . During the same period patient was treated with DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), AVASTIN (View Avastin Review and Avastin Label ), XELODA (View Xeloda Review and Xeloda Label ), ELPLAT (View Elplat Review and Elplat Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ). Patient was hospitalized.

6958545-6 | Blood Creatinine Increased, Blood Urea Increased, Pleural Effusion
Adverse event was reported on Aug 24, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: JAPAN , 70 years of age, Patient had the following side effects: blood creatinine increased, blood urea increased, pleural effusion. During the same period patient was treated with TOUGHMAC E (View Toughmac E Review and Toughmac E Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), PLATOSIN (View Platosin Review and Platosin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), NATRIX (View Natrix Review and Natrix Label ), MICARDIS (View Micardis Review and Micardis Label ), RIZE (View Rize Review and Rize Label ). Patient was hospitalized.

6956863-9 | Hepatitis, Metabolic Acidosis, Sensory Disturbance
on Aug 24, 2010 Female patient from NETHERLANDS , 69 years of age, weighting 108.0 lb, was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: hepatitis (What is hepatitis?), metabolic acidosis, sensory disturbance. Emend dosage: . During the same period patient was treated with MEBEVERINE PAMOATE (View Mebeverine Pamoate Review and Mebeverine Pamoate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), MESNA (View Mesna Review and Mesna Label ).

6955952-2 | Hepatic Function Abnormal
on Aug 24, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Emend dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), BRIPLATIN (View Briplatin Review and Briplatin Label ), DECADRON (View Decadron Review and Decadron Label ), SEROTONE (View Serotone Review and Serotone Label ). Patient was hospitalized.

6936784-8 | Convulsion, Headache
Patient was taking Emend (View Usage). Patient had the following side effects: convulsion, headache (What is headache?) on Aug 17, 2010 from JAPAN Additional patient health information: Male patient , 51 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant, brain cancer metastatic and. Emend dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), BRIPLATIN (View Briplatin Review and Briplatin Label ), NAVELBINE (View Navelbine Review and Navelbine Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ).

6923366-7 | Convulsion
Adverse event was reported on Aug 10, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: JAPAN , 49 years of age, After Emend was administered, patient had the following side effects: convulsion. During the same period patient was treated with BRIPLATIN (View Briplatin Review and Briplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TAKEPRON (View Takepron Review and Takepron Label ), OPSO (View Opso Review and Opso Label ), PEPCID RPD (View Pepcid Rpd Review and Pepcid Rpd Label ), RAMELTEON (View Ramelteon Review and Ramelteon Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ).

6922169-7 | Blood Pressure Increased, Convulsion, Increased Upper Airway Secretion, Somnolence, Tonic Convulsion, Urinary Incontinence
on Aug 09, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, convulsion, increased upper airway secretion, somnolence, tonic convulsion, urinary incontinence (What is urinary incontinence?). Emend dosage: . During the same period patient was treated with BRIPLATIN (View Briplatin Review and Briplatin Label ), CAMPTOSAR (View Camptosar Review and Camptosar Label ), DEPAKENE (View Depakene Review and Depakene Label ), DECADRON (View Decadron Review and Decadron Label ), RAMELTEON (View Ramelteon Review and Ramelteon Label ), UNASYN (View Unasyn Review and Unasyn Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6921598-5 | Body Temperature Decreased, Dystonia, Hypertension
on Aug 05, 2010 Male patient from UNITED STATES , 44 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient had the following side effects: body temperature decreased, dystonia (What is dystonia?), hypertension. Emend dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), CAMPTOSAR (View Camptosar Review and Camptosar Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), COMPAZINE (View Compazine Review and Compazine Label ).

6917267-8 | Hypotension, Loss Of Consciousness, Malaise, Supraventricular Tachycardia
Patient was taking Emend (View Usage). After Emend was administered, patient had the following side effects: hypotension, loss of consciousness, malaise, supraventricular tachycardia on Aug 02, 2010 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Emend dosage: . During the same period patient was treated with FASTURTEC (View Fasturtec Review and Fasturtec Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZOPHREN (View Zophren Review and Zophren Label ). Patient was hospitalized.

6911160-2 | Rash, Tubulointerstitial Nephritis
Adverse event was reported on Aug 02, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with metastatic malignant melanoma, bronchitis (What is bronchitis?) and. Location: FRANCE , 70 years of age, Patient experienced the following unwanted or unexpected effects: rash (What is rash?), tubulointerstitial nephritis. During the same period patient was treated with DETICENE (View Deticene Review and Deticene Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

6888155-0 | Agranulocytosis
on Jul 22, 2010 Female patient from SWITZERLAND , 63 years of age, was diagnosed with prophylaxis of nausea and vomiting, b-cell lymphoma, pain in extremity and was treated with Emend (View Usage). Patient had the following side effects: agranulocytosis. Emend dosage: . During the same period patient was treated with RIBOMUSTIN (View Ribomustin Review and Ribomustin Label ), MABTHERA (View Mabthera Review and Mabthera Label ), PONSTAN (View Ponstan Review and Ponstan Label ), PASPERTIN (View Paspertin Review and Paspertin Label ), NAVOBAN (View Navoban Review and Navoban Label ), FORTECORTIN (View Fortecortin Review and Fortecortin Label ).

6876052-6 | Constipation, Disease Progression, Haemorrhoids, Leiomyosarcoma, Pain
on Jun 28, 2010 Female patient from UNITED STATES , 40 years of age, was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: constipation (What is constipation?), disease progression, haemorrhoids, leiomyosarcoma, pain (What is pain?). Emend dosage: .

6867328-7 | Constipation, Disease Progression, Off Label Use
Patient was taking Emend (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), disease progression, off label use on Jun 28, 2010 from UNITED STATES Additional patient health information: Male patient , 17 years of age, . Emend dosage: .

6866487-X | Anaphylactic Reaction
Adverse event was reported on Apr 06, 2010 by a Female patient taking Emend (View Usage) (Dosage: 2 Mg/iv) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: anaphylactic reaction. Patient was hospitalized.

6863044-6 | Hepatic Function Abnormal
on Jul 13, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: hepatic function abnormal. Emend dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), BRIPLATIN (View Briplatin Review and Briplatin Label ). Patient was hospitalized.

6836341-8 | Cerebral Haemorrhage
on Jul 09, 2010 Female patient from SPAIN , 68 years of age, was diagnosed with vomiting, lung neoplasm malignant, prophylaxis against gastrointestinal ulcer and was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Emend dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), GEMCITABINE HYDROCHLORIDE (View Gemcitabine Hydrochloride Review and Gemcitabine Hydrochloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), EBASTINE (View Ebastine Review and Ebastine Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ). Patient was hospitalized.

6831918-8 | Inappropriate Antidiuretic Hormone Secretion
Patient was taking Emend (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion on Jul 01, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Emend dosage: . During the same period patient was treated with PLATOSIN (View Platosin Review and Platosin Label ), VEPESID (View Vepesid Review and Vepesid Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), OMEPRAL (View Omepral Review and Omepral Label ), LASTET (View Lastet Review and Lastet Label ). Patient was hospitalized.

6827045-6 | Convulsion, Grand Mal Convulsion
Adverse event was reported on Jun 30, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: JAPAN , 49 years of age, After Emend was administered, patient had the following side effects: convulsion, grand mal convulsion. During the same period patient was treated with BRIPLATIN (View Briplatin Review and Briplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TAKEPRON (View Takepron Review and Takepron Label ), OPSO (View Opso Review and Opso Label ), PEPCID RPD (View Pepcid Rpd Review and Pepcid Rpd Label ), RAMELTEON (View Ramelteon Review and Ramelteon Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ).

6817826-7 | Anaemia, Fatigue, Muscle Twitching, Nausea
on Jul 01, 2010 Female patient from UNITED STATES , 47 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, fatigue, muscle twitching, nausea (What is nausea?). Emend dosage: . During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ALOXI (View Aloxi Review and Aloxi Label ), TAGAMET (View Tagamet Review and Tagamet Label ).

6815799-4 | Constipation
on Jun 28, 2010 Female patient from UNITED STATES , 40 years of age, was treated with Emend (View Usage). Patient had the following side effects: constipation (What is constipation?). Emend dosage: .

6815793-3 | Constipation
Patient was taking Emend (View Usage). After Emend was administered, patient had the following side effects: constipation (What is constipation?) on Jun 28, 2010 from UNITED STATES Additional patient health information: Male patient , 17 years of age, . Emend dosage: .

6813746-2 | Convulsion
Adverse event was reported on Jun 21, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: convulsion. During the same period patient was treated with BRIPLATIN (View Briplatin Review and Briplatin Label ), CAMPTOSAR (View Camptosar Review and Camptosar Label ), DEPAKENE (View Depakene Review and Depakene Label ), DECADRON (View Decadron Review and Decadron Label ), RAMELTEON (View Ramelteon Review and Ramelteon Label ), UNASYN (View Unasyn Review and Unasyn Label ).

6813738-3 | Cytolytic Hepatitis
on Jun 28, 2010 Female patient from FRANCE , 34 years of age, was treated with Emend (View Usage). Patient had the following side effects: cytolytic hepatitis. Emend dosage: . During the same period patient was treated with BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL (View Phloroglucinol And Trimethylphloroglucinol Review and Phloroglucinol And Trimethylphloroglucinol Label ). Patient was hospitalized.

6803554-0 | Convulsion
on Jun 21, 2010 Male patient from JAPAN , 51 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant, brain cancer metastatic and was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: convulsion. Emend dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), BRIPLATIN (View Briplatin Review and Briplatin Label ), NAVELBINE (View Navelbine Review and Navelbine Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ).

6784360-2 | Decreased Appetite, Depressive Symptom, Dizziness, Dyspnoea, Headache, Palpitations
Patient was taking Emend (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, depressive symptom, dizziness (What is dizziness?), dyspnoea, headache (What is headache?), palpitations on Jun 10, 2010 from JAPAN Additional patient health information: Female patient , 46 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Emend dosage: . During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ), DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

6782137-5 | Adverse Event, Angioedema, Urticaria
Adverse event was reported on Jun 15, 2010 by a Female patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED STATES , 46 years of age, Patient had the following side effects: adverse event, angioedema, urticaria. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), NEULASTA (View Neulasta Review and Neulasta Label ), MESNA (View Mesna Review and Mesna Label ), ATIVAN (View Ativan Review and Ativan Label ), COMPAZINE (View Compazine Review and Compazine Label ), SINGULAIR (View Singulair Review and Singulair Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized and became disabled.

6760487-6 | Hiccups
on May 18, 2009 Male patient from UNITED STATES , 71 years of age, weighting 211.0 lb, was diagnosed with prophylaxis, prophylaxis of nausea and vomiting and was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: hiccups. Emend dosage: 125 Mg/1x/po ; 125 Mg/1x/po. During the same period patient was treated with CYCLOPHOSPHAMIDE (+) DOXORUBICIN (View Cyclophosphamide (+) Doxorubicin Review and Cyclophosphamide (+) Doxorubicin Label ).

6760483-9 | Dysphagia, Dyspnoea, Erythema, Flushing, Pruritus, Sensation Of Foreign Body
on Nov 23, 2009 Female patient from UNITED STATES , 35 years of age, weighting 147.0 lb, was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, dyspnoea, erythema, flushing, pruritus, sensation of foreign body. Emend dosage: 125 Mg/1x/po ; 80 Mg/1x/po. During the same period patient was treated with ADRIAMYCIN PFS (109 Mg/m[2]/daily/iv) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CELEXA (View Celexa Review and Celexa Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), DECADRON (View Decadron Review and Decadron Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), NEURONTIN (View Neurontin Review and Neurontin Label ).

6756636-6 | Dysgeusia, Renal Impairment
Patient was taking Emend (View Usage). Patient had the following side effects: dysgeusia, renal impairment on May 28, 2010 from JAPAN Additional patient health information: Female patient , 52 years of age, was diagnosed with prophylaxis of nausea and vomiting, non-small cell lung cancer and. Emend dosage: . During the same period patient was treated with RANDA (View Randa Review and Randa Label ), DECADRON (View Decadron Review and Decadron Label ), KYTRIL (View Kytril Review and Kytril Label ), NAVELBINE (View Navelbine Review and Navelbine Label ).

6749830-1 | Altered State Of Consciousness, Hepatic Function Abnormal, Hyperammonaemia
Adverse event was reported on May 17, 2010 by a Female patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting, oesophageal carcinoma and. Location: JAPAN , 67 years of age, After Emend was administered, patient had the following side effects: altered state of consciousness, hepatic function abnormal, hyperammonaemia. During the same period patient was treated with DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), ATARAX (View Atarax Review and Atarax Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), AQUPLA (View Aqupla Review and Aqupla Label ). Patient was hospitalized.

6747496-8 | Convulsion
on May 19, 2010 Male patient from JAPAN , 27 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Emend dosage: .

6744313-7 | Altered State Of Consciousness, Hepatic Function Abnormal, Hyperammonaemia
on May 17, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with prophylaxis of nausea and vomiting, oesophageal carcinoma and was treated with Emend (View Usage). Patient had the following side effects: altered state of consciousness, hepatic function abnormal, hyperammonaemia. Emend dosage: . During the same period patient was treated with DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), ATARAX (View Atarax Review and Atarax Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), AQUPLA (View Aqupla Review and Aqupla Label ). Patient was hospitalized.

6740284-8 | Tardive Dyskinesia
Patient was taking Emend (View Usage). After Emend was administered, patient had the following side effects: tardive dyskinesia on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Emend dosage: . During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ).

6740267-8 | Cerebral Haemorrhage
Adverse event was reported on May 21, 2010 by a Female patient taking Emend (View Usage) (Dosage: ) was diagnosed with vomiting, lung neoplasm malignant, prophylaxis against gastrointestinal ulcer and. Location: SPAIN , 68 years of age, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. During the same period patient was treated with ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), EBASTINE (View Ebastine Review and Ebastine Label ), GEMCITABINE HYDROCHLORIDE (View Gemcitabine Hydrochloride Review and Gemcitabine Hydrochloride Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6738916-3 | Erythema Multiforme, Toxic Epidermal Necrolysis
on May 19, 2010 Female patient from UNITED KINGDOM , 44 years of age, weighting 154.3 lb, was diagnosed with nausea (What is nausea?), pain (What is pain?), constipation (What is constipation?) and was treated with Emend (View Usage). Patient had the following side effects: erythema multiforme, toxic epidermal necrolysis. Emend dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), PREMARIN (View Premarin Review and Premarin Label ).

6736441-7 | Dysphagia, Hyporeflexia
on May 17, 2010 Female patient from UNITED KINGDOM , 49 years of age, weighting 189.6 lb, was diagnosed with nausea (What is nausea?) and was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: dysphagia, hyporeflexia. Emend dosage: . During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN HYDROCHLORIDE (View Epirubicin Hydrochloride Review and Epirubicin Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6734100-8 | Gastric Ulcer Haemorrhage
Patient was taking Emend (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer haemorrhage on May 11, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with prophylaxis of nausea and vomiting, colon cancer and. Emend dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), XELODA (View Xeloda Review and Xeloda Label ), DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), ELPLAT (View Elplat Review and Elplat Label ). Patient was hospitalized.

6726702-X |
Adverse event was reported on May 11, 2010 by a Male patient taking Emend (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED KINGDOM , 55 years of age, . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ).

6726039-9 | Ulcerative Keratitis
on May 10, 2010 Female patient from SPAIN , 51 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer metastatic and was treated with Emend (View Usage). After Emend was administered, patient had the following side effects: ulcerative keratitis. Emend dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ).

6724723-4 | Erythema Multiforme, Toxic Epidermal Necrolysis
on May 10, 2010 Female patient from UNITED KINGDOM , 44 years of age, weighting 154.3 lb, was diagnosed with nausea (What is nausea?), gastrooesophageal reflux disease, dyspepsia and was treated with Emend (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, toxic epidermal necrolysis. Emend dosage: . During the same period patient was treated with CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6724230-9 | Encephalopathy
Patient was taking Emend (View Usage). Patient had the following side effects: encephalopathy on May 07, 2010 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with prophylaxis of nausea and vomiting, sarcoma uterus and. Emend dosage: . During the same period patient was treated with DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ). Patient was hospitalized.